Since insoluble aggregates reduce expression levels of soluble PABPN1 [9], it suggests that reduced levels of soluble PABPN1 could cause muscle weakness in OPMD. The gene discussed is PABPN1; the disease is oculopharyngeal muscular dystrophy.